Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
By Brendan Pierson (Reuters) – Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood…